
Innovent Biologics
VerifiedInnovent Biologics is a biopharmaceutical company developing and manufacturing monoclonal antibodies
Suzhou China (HQ), United States
Company information
EditDate | Investors | Amount | Round |
---|---|---|---|
$5m | SERIES A | ||
$25m | SERIES B | ||
$115m | SERIES C | ||
$260m | SERIES D | ||
$150m Valuation: $1.0b | SERIES E | ||
N/A | $421m Valuation: $2.0b | IPO | |
Total Funding | €505m |
Recent News about Innovent Biologics
EditLocationEdit
China, Suzhou